Associate, Technology & Life Sciences group, Goodwin Law
Alexander Varond is an associate in Goodwin’s Technology & Life Sciences group. Mr. Varond advises drug, biotech, and device clients on a wide range of FDA regulatory matters. He has extensive experience in medical device and drug development, Hatch-Waxman patent and exclusivity issues, and regulatory strategy. Mr. Varond also counsels on advertising and promotional issues, defends companies during civil and criminal investigations on a variety of issues, including off-label promotion and GMPs, and regularly advises on corporate transactions. Prior to joining Goodwin in 2017, Mr. Varond was a senior associate at Hyman, Phelps & McNamara, PC. His perspective is bolstered by having worked closely alongside numerous in-house regulatory and legal teams through various critical projects, including NDA preparation, formal dispute resolutions, FDA and regulatory strategy advisory meetings, and product launches. In 2018, LMG Life Sciences awarded Mr. Varond its U.S. Regulatory Rising Star Award in recognition of his experience in FDA regulatory law.